NetraMark HoldingsAINMF +14.62%31 9-Day RSI is 38.61 as of Jul. 06, 2026. GuruFocus rates AINMF with a GF Score™ of 31/100 and a GF Value™ of $0.18 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 697 Healthcare Providers & Services companies, NetraMark Holdings ranks worse than 65.71% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 9-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.
NetraMark Holdings 9-Day RSI Related Terms
AINMF vs VEEV, BTSG, TEM: 9-Day RSI Comparison
For the Health Information Services subindustry, NetraMark Holdings's 9-Day RSI, along with its competitors' market caps and 9-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NetraMark Holdings 9-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's 9-Day RSI distribution charts can be found below:
* The bar in red indicates where NetraMark Holdings's 9-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NetraMark Holdings (AINMF) has a 9-Day RSI of 38.61 as of Jul. 06, 2026. According to the industry distribution chart, NetraMark Holdings ranks #458 out of 697 companies in the Healthcare Providers & Services industry, placing it in the top 65.7%.
Is NetraMark Holdings' 9-Day RSI too high?
NetraMark Holdings' current 9-Day RSI is 38.61. The Healthcare Providers & Services industry median 9-Day RSI is 52.67. NetraMark Holdings' value of 38.61 is 26.7% below this industry median. Based on the distribution chart, NetraMark Holdings ranks #458 out of 697 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, NetraMark Holdings has a GF Score™ of 31/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NetraMark Holdings' 9-Day RSI compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, NetraMark Holdings ranks #458 out of 697 companies for 9-Day RSI. This places NetraMark Holdings in the lower half of its industry. The industry median 9-Day RSI is 52.67. NetraMark Holdings' value of 38.61 is 26.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 9-Day RSI for a Healthcare Providers & Services company?
The median 9-Day RSI among Healthcare Providers & Services companies is 52.67, based on 697 companies in the industry. Companies in the top quartile (top 25%) have a 9-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 9-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NetraMark Holdings's current 9-Day RSI of 38.61 is 26.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 9-Day RSI mean?
A high 9-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median 9-Day RSI is 52.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NetraMark Holdings's current 9-Day RSI is 38.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NetraMark Holdings stock overvalued right now?
Based on GuruFocus' analysis, NetraMark Holdings (AINMF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.18, compared to a current price of $0.46 — trading 155.6% above its estimated fair value. The current 9-Day RSI is 38.61 and 26.7% below the Healthcare Providers & Services industry median of 52.67. NetraMark Holdings' overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 9-Day RSI calculated?
9-Day RSI is calculated from a company's financial statements. For NetraMark Holdings (AINMF), the current 9-Day RSI is 38.61 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NetraMark Holdings (AINMF) Overvalued in 2026?
Based on GuruFocus' analysis, NetraMark Holdings stock appears to be overvalued.
The current stock price of $0.46 is trading 155.6% above its estimated GF Value™ of $0.18.
GuruFocus considers NetraMark Holdings to be Significantly Overvalued.
Key valuation signals for AINMF:
9-Day RSI: 38.61
GF Value™: $0.18 vs. price of $0.46 (155.6% above fair value)
Industry Position: 26.7% below the Healthcare Providers & Services median (#458 of 697)
No single metric tells the full story. See the AINMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NetraMark Holdings Inc provides AI-powered insights and software solutions to optimize clinical trial design and outcomes for pharmaceutical sponsors. The company offers AI solutions to trial sponsors, CROs, and biotechnology companies across the globe. It earns revenue from its proprietary NetraAI platform, an advanced machine learning system purpose-built to analyze complex clinical trial data and identify meaningful patient subpopulations.
31GF Score
Get the complete analysis for AINMF
9-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AINMF has been successfully added to your 